Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)

相似書籍

• A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
  由: Quartier, Pierre, et al.
  出版: (2010)
• Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
  由: Urien, Saik, et al.
  出版: (2013)
• PReS-FINAL-2111: Cytomegalovirus, Epstein Barr virus and Varicella-Zoster virus infections in children with juvenile idiopathic arthritis treated with biologics
  由: Remy Piccolo, V, et al.
  出版: (2013)
• Anakinra in children and adults with Still’s disease
  由: Vastert, Sebastiaan J, et al.
  出版: (2019)
• Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
  由: Nemiche, O, et al.
  出版: (2011)